Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults. [electronic resource]
Producer: 20120710Description: 134-9 p. digitalISSN:- 1095-8320
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Antibodies, Viral -- blood
- Child
- Child, Preschool
- Dose-Response Relationship, Immunologic
- Female
- HIV Infections -- complications
- Humans
- Immunization Schedule
- Influenza A Virus, H1N1 Subtype -- immunology
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- complications
- Male
- Polysorbates -- administration & dosage
- Prospective Studies
- Safety
- Squalene -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.